Serdolect

Country: New Zealand

Language: English

Source: Medsafe (Medicines Safety Authority)

Active ingredient:

Sertindole 20mg

Available from:

Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics

INN (International Name):

Sertindole 20 mg

Dosage:

20 mg

Pharmaceutical form:

Film coated tablet

Composition:

Active: Sertindole 20mg Excipient: Croscarmellose sodium Hyprolose Lactose monohydrate Magnesium stearate Maize starch Microcrystalline cellulose Opadry pink 03B24282

Units in package:

Blister pack, PVC/PVDC/Al, 20 tablets

Class:

Prescription

Prescription type:

Prescription

Manufactured by:

Lundbeck Pharmaceuticals Italy SpA

Therapeutic indications:

Sertindole is indicated for the treatment of schizophrenia. Due to cardiovascular safety concerns, sertindole should only be used for patients intolerant to at least one other antipsychotic agent. Sertindole should not be used in emergency situations for urgent relief of symptoms in acutely disturbed patients.

Product summary:

Package - Contents - Shelf Life: Blister pack, PVC/PVDC/Al - 20 tablets - 60 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC/Al - 28 tablets - 60 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC/Al - 30 tablets - 60 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC/Al - 50 tablets - 60 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC/Al - 98 tablets - 60 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC/Al - 100 tablets - 60 months from date of manufacture stored at or below 25°C

Authorization date:

2006-04-13